Full Text View
Tabular View
No Study Results Posted
Related Studies
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
This study is currently recruiting participants.
Verified February 2013 by National Cancer Institute (NCI)
Study NCT01105312   Information provided by National Cancer Institute (NCI)

First Received on April 15, 2010.   Last Updated on February 22, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Additional conditions recognized in this trial
Breast Neoplasms
More general conditions related to this trial
Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
letrozole
panobinostat
RNA analysis
microarray analysis
enzyme-linked immunosorbent assay
laboratory biomarker analysis
More general drug interventions related to this trial
Antineoplastic Agents
Aromatase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
North Central Cancer Treatment Group
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services